BIM
KYNB

Bogle Investment Management’s Kyntra Bio KYNB Stock Holding History

Bogle Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,818
Closed -$5.13M – 305
2017
Q3 		$5.13M Sell
3,818
-9,357
-71% -$9.86M 0.35% 107
2017
Q2 		$10.6M Hold
13,175
– – 0.78% 53
2017
Q1 		$8.12M Buy
13,175
+9,003
+216% +$5.48M 0.57% 76
2016
Q4 		$2.23M Buy
+4,172
New +$2.08M 0.15% 166
2016
Q3 		– Sell
-2,628
Closed -$1.08M – 381
2016
Q2 		$1.08M Buy
+2,628
New +$1.2M 0.07% 271
2015
Q4 		– Sell
-9,367
Closed -$5.13M – 399
2015
Q3 		$5.13M Sell
9,367
-8,873
-49% -$5.38M 0.36% 99
2015
Q2 		$10.7M Buy
18,240
+17,945
+6,083% +$10.4M 0.8% 26
2015
Q1 		$231K Buy
+295
New +$229K 0.02% 325

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bogle Investment Management's KYNB Position: Q4 2017 in Review

Bogle Investment Management sold out of Kyntra Bio (KYNB) in Q4 2017, closing a stake of 3,818 shares — an estimated $5.13M sold.

Bogle Investment Management first reported a position in KYNB in Q1 2015 and held it in 8 quarters. The position peaked at $10.7M in Q2 2015. 187 funds tracked by Wall St. Rank hold KYNB as of Q4 2017.

  • Bogle Investment Management reported no remaining Kyntra Bio position as of Q4 2017 after selling out during the quarter.
  • Bogle Investment Management sold 3,818 Kyntra Bio shares in Q4 2017, an estimated $5.13M.
  • Bogle Investment Management first reported a position in Kyntra Bio in Q1 2015 and held it in 8 quarters.
  • Bogle Investment Management's Kyntra Bio position peaked at $10.7M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2017.

Based on Bogle Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.